Pieter Jan van Ooij

Dr. Pieter Jan van Ooij

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
POPieter Jan van Ooij
Pieter Jan van Ooij
MHM.W. Hollmann
M.W. Hollmann
RHR.A. van Hulst
R.A. van Hulst
PSP.J. Sterk
P.J. Sterk

30 November 2016 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
POPieter Jan van Ooij
Pieter Jan van Ooij
PSPeter J. Sterk
Peter J. Sterk
RHRobert A. van Hulst
Robert A. van Hulst
Worldwide, the number of professional and sports divers is increasing. Most of them breathe diving gases with a raised partial pressure of oxygen (PO2). However, if thePO2is between 50 and 300 kPa (375–2250 mmHg) (hyperoxia), pathological pulmonary changes can develop, known as pulmonary oxygen toxicity (POT). Although in its acute phase, POT is reversible, it can ultimately lead to non-reversible pathological changes. Therefore, it is important to monitor these divers to prevent them from sustaining irreversible lesions.This review summarises the pulmonary pathophysiological effects when breathing oxygen with aPO2of 50–300 kPa (375–2250 mmHg). We describe the role and the limitations of lung function testing in monitoring the onset and development of POT, and discuss new techniques in respiratory medicine as potential markers in the early development of POT in divers.

21 June 2011 in Clinical Physiology and Functional Imaging
Verified
Journal Article
Closed access
PDF file
POPieter Jan van Ooij
Pieter Jan van Ooij
RHR. A. van Hulst
R. A. van Hulst
AHA. Houtkooper
A. Houtkooper
PSP. J. Sterk
P. J. Sterk

1 July 2014 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
POPieter Jan van Ooij
Pieter Jan van Ooij
RHR.A. van Hulst
R.A. van Hulst
WKW. Kulik
W. Kulik
PBP. Brinkman
P. Brinkman
AHA. Houtkooper
A. Houtkooper
PSP.J. Sterk
P.J. Sterk

21 February 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
FJFeiko Jaime Michiel de Jong
Feiko Jaime Michiel de Jong
Thijs WingelaarThijs Wingelaar
Thijs Wingelaar
PBPaul Brinkman
Paul Brinkman
POPieter Jan van Ooij
Pieter Jan van Ooij
Anke H. Maitland-van der ZeeAnke H. Maitland-van der Zee
Anke H. Maitland-van der Zee
Robert A. Van HulstRobert A. Van Hulst
Robert A. Van Hulst
The COMEX-30 hyperbaric treatment table is used to manage decompression sickness in divers but may result in pulmonary oxygen toxicity (POT). Volatile organic compounds (VOCs) in exhaled breath are early markers of hyperoxic stress that may be linked to POT. The present study assessed whether VOCs following COMEX-30 treatment are early markers of hyperoxic stress and/or POT in ten healthy, nonsmoking volunteers. Because more oxygen is inhaled during COMEX-30 treatment than with other treatment tables, this study hypothesized that VOCs exhaled following COMEX-30 treatment are indicators of POT. Breath samples were collected before and 0.5, 2, and 4 h after COMEX-30 treatment. All subjects were followed-up for signs of POT or other symptoms. Nine compounds were identified, with four (nonanal, decanal, ethyl acetate, and tridecane) increasing 33–500% in intensity from before to after COMEX-30 treatment. Seven subjects reported pulmonary symptoms, five reported out-of-proportion tiredness and transient ear fullness, and four had signs of mild dehydration. All VOCs identified following COMEX-30 treatment have been associated with inflammatory responses or pulmonary diseases, such as asthma or lung cancer. Because most subjects reported transient pulmonary symptoms reflecting early-stage POT, the identified VOCs are likely markers of POT, not just hyperbaric hyperoxic exposure.

6 September 2013 in Clinical Physiology and Functional Imaging
Verified
Journal Article
Closed access
PDF file
POPieter Jan van Ooij
Pieter Jan van Ooij
RHR. A. van Hulst
R. A. van Hulst
AHA. Houtkooper
A. Houtkooper
PSP. J. Sterk
P. J. Sterk